Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AdaptHealth Corp. Director's Dealing 2021

Jan 6, 2021

32107_dirs_2021-01-05_573c844f-ae47-4cae-a299-61f51ef2981d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AdaptHealth Corp. (AHCO)
CIK: 0001725255
Period of Report: 2020-12-31

Reporting Person: McGee Luke (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-31 Class A Common Stock M 150000 Acquired 427151 Indirect
2021-01-01 Class A Common Stock M 239793 Acquired 666944 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-31 Class B Common Stock $ M 150000 Disposed Class A Common Stock (150000) Indirect
2020-12-31 Warrants $11.5 G 93212 Disposed Class A Common Stock (93212) Indirect
2020-12-31 Warrants $11.5 G 78525 Disposed Class A Common Stock (78525) Indirect
2020-12-31 Warrants $11.5 G 52384 Disposed Class A Common Stock (52384) Indirect
2021-01-01 Class B Common Stock $ M 239793 Disposed Class A Common Stock (239793) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Class A Common Stock 296250 Direct
Class A Common Stock 1752056 Indirect
Class A Common Stock 1168800 Indirect

Footnotes

F1: Represents shares of Class A Common Stock of the Issuer issued upon an exchange of an equivalent number of shares of Class B Common Stock of the Issuer pursuant to the terms of that certain Exchange Agreement, dated as of November 8, 2019 (the "Exchange Agreement"), by and among the Issuer, AdaptHealth Holdings LLC and the other parties thereto (together with the same number of common units of AdaptHealth Holdings LLC).

F2: Securities held directly by 2321 Capital LLC.

F3: Securities held directly by Fresh Pond Investment LLC.

F4: Securities held directly by LBM DBE Holdings LLC.

F5: The Class B Common Stock was exchangeable (together with the same number of common units of AdaptHealth Holdings LLC) for shares of Class A Common Stock of the Issuer (or the cash value thereof).

F6: The Warrants were exercisable commencing on December 8, 2019. The Warrants are subject to redemption upon the terms provided in the warrant agreement. The Warrants expire November 8, 2024 or earlier upon redemption or liquidation.